86 related articles for article (PubMed ID: 11820611)
1. Cytotoxicity activity of L-proline analogues of anthraquinone-2-carboxylic acid in breast cancer MCF-7 cells.
Bielawska A; Bielawski K; Pałka J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():207-8. PubMed ID: 11820611
[TBL] [Abstract][Full Text] [Related]
2. L-proline analogues of anthraquinone-2-carboxylic acid: cytotoxic activity in breast cancer MCF-7 cells and inhibitory activity against topoisomerase I and II.
Bielawska A; Kosk K; Bielawski K
Pol J Pharmacol; 2001; 53(3):283-7. PubMed ID: 11785929
[TBL] [Abstract][Full Text] [Related]
3. Proline analogue of melphalan as a prolidase-convertible pro-drug in breast cancer MCF-7 cells.
Chrzanowski K; Pałka J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():209-11. PubMed ID: 11820612
[TBL] [Abstract][Full Text] [Related]
4. Prolidase as a prodrug converting enzyme. II. Synthesis of proline analogue of anthraquinone-2-carboxylic acid and its susceptibility to the action of prolidase.
Bielawska A; Bielawski K; Pałka J
Rocz Akad Med Bialymst; 1998; 43():201-9. PubMed ID: 9972056
[TBL] [Abstract][Full Text] [Related]
5. Prolidase-activated prodrug for cancer chemotherapy cytotoxic activity of proline analogue of chlorambucil in breast cancer MCF-7 cells.
Bielawska A; Bielawski K; Chrzanowski K; Wołczyński S
Farmaco; 2000; 55(11-12):736-41. PubMed ID: 11204951
[TBL] [Abstract][Full Text] [Related]
6. Decreased cytotoxicity and increased antimitotic activity of a proline analogue of chlorambucil as a prodrug susceptible to the action of fibroblast's prolidase.
Bielawska A; Chrzanowski K; Bielawski K; Pałka J
Pharmazie; 2001 Apr; 56(4):290-4. PubMed ID: 11338665
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity and effect on collagen biosynthesis of proline analogue of melphalan as a prolidase-convertible prodrug in cultured human skin fibroblasts.
Chrzanowski K; Bielawska A; Bielawski K; Wołczyński S; Pałka J
Farmaco; 2001 Sep; 56(9):701-6. PubMed ID: 11680815
[TBL] [Abstract][Full Text] [Related]
8. Prolidase, a potential enzyme target for melanoma: design of proline-containing dipeptide-like prodrugs.
Mittal S; Song X; Vig BS; Landowski CP; Kim I; Hilfinger JM; Amidon GL
Mol Pharm; 2005; 2(1):37-46. PubMed ID: 15804176
[TBL] [Abstract][Full Text] [Related]
9. Proline-linked nitrosoureas as prolidase-convertible prodrugs in human breast cancer cells.
Bielawski K; Bielawska A; Słodownik T; Bołkun-Skórnicka U; Muszyńska A
Pharmacol Rep; 2008; 60(2):171-82. PubMed ID: 18443378
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.
Teng CH; Won SJ; Lin CN
Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756
[TBL] [Abstract][Full Text] [Related]
11. Prolidase as a prodrug converting enzyme. III. Synthesis of proline analogues of melphalan and theirs susceptibility to the action of prolidase.
Bielawska A; Bielawski K; Pałka J
Rocz Akad Med Bialymst; 1999; 44():190-9. PubMed ID: 10697434
[TBL] [Abstract][Full Text] [Related]
12. Proline analogue of melphalan as a prodrug susceptible to the action of prolidase in breast cancer MDA-MB 231 cells.
Chrzanowski K; Bielawska A; Pałka J
Farmaco; 2003 Nov; 58(11):1113-9. PubMed ID: 14572862
[TBL] [Abstract][Full Text] [Related]
13. Development of methotrexate proline prodrug to overcome resistance by MDA-MB-231 cells.
Wu Z; Shah A; Patel N; Yuan X
Bioorg Med Chem Lett; 2010 Sep; 20(17):5108-12. PubMed ID: 20674353
[TBL] [Abstract][Full Text] [Related]
14. Prolidase as a prodrug converting enzyme I. Synthesis of proline analogue of chlorambucil and its susceptibility to the action of prolidase.
Bielawska A; Bielawski K; Pałka J
Rocz Akad Med Bialymst; 1997; 42(1):148-55. PubMed ID: 9581474
[TBL] [Abstract][Full Text] [Related]
15. Decreased cytotoxicity and increased antimitotic activity of proline analogue of chlorambucil as a prodrug in breast cancer MCF-7 cells.
Bielawska A; Chrzanowski K; Bielawski K; Pałka J
Acta Pol Pharm; 2000 Nov; 57 Suppl():103-5. PubMed ID: 11293233
[No Abstract] [Full Text] [Related]
16. Proline prodrug of melphalan targeted to prolidase, a prodrug activating enzyme overexpressed in melanoma.
Mittal S; Song X; Vig BS; Amidon GL
Pharm Res; 2007 Jul; 24(7):1290-8. PubMed ID: 17377743
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytotoxic effect of 1,3-dihydroxy-9,10-anthraquinone derivatives.
Wei BL; Wu SH; Chung MI; Won SJ; Lin CN
Eur J Med Chem; 2000 Dec; 35(12):1089-98. PubMed ID: 11248407
[TBL] [Abstract][Full Text] [Related]
18. Involvement of hydroxyl radical formation and DNA strand breakage in the cytotoxicity of anthraquinone antitumour agents.
Fisher GR; Brown JR; Patterson LH
Free Radic Res Commun; 1990; 11(1-3):117-25. PubMed ID: 1963615
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, DNA binding, and cytotoxicity of 1,4-bis(2-amino-ethylamino)anthraquinone-amino acid conjugates.
Hsin LW; Wang HP; Kao PH; Lee O; Chen WR; Chen HW; Guh JH; Chan YL; His CP; Yang MS; Li TK; Lee CH
Bioorg Med Chem; 2008 Jan; 16(2):1006-14. PubMed ID: 17962028
[TBL] [Abstract][Full Text] [Related]
20. Acetylsalicylic acid as a potential regulator of prolidase-convertible pro-drugs in control and neoplastic cells.
Chrzanowski K; Bielawska A; Bielawski K; Pałka J; Wołczyński S
Farmaco; 2004 Sep; 59(9):679-84. PubMed ID: 15337432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
